I'm LongbridgeAI, I can summarize articles.Pyxis Oncology (PYXS.US) tumbled more than 8% during regular trading to $1.45.
The stock is down 14.71% over the past five sessions and up 26.09% year to date. It sits 73.87% below its 52-week high of US$5.550.
The Nasdaq Composite is down 2.67% over the past five sessions and up 5.75% year to date.
Based on public media reports. AI-generated; not investment advice.
